Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(20/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(20/week)
News
United States
(1284/week)
Manufacturing
(644/week)
Technology
(1299/week)
Energy
(496/week)
Other Manufacturing
(448/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Blueprint Medicines Corporation
Oct 29, 2020
Blueprint Medicines Reports Third Quarter 2020 Financial Results
Oct 22, 2020
Blueprint Medicines to Report Third Quarter 2020 Financial Results on Thursday, October 29, 2020
Sep 17, 2020
Blueprint Medicines Presents Foundational Preclinical Data for BLU-945 Showing Robust Anti-Tumor Activity in Treatment-Resistant EGFR-Mutated Lung Cancer at ESMO Virtual Congress 2020
Sep 09, 2020
Blueprint Medicines to Present at 18th Annual Morgan Stanley Global Healthcare Conference
Sep 01, 2020
Blueprint Medicines Strengthens Leadership with Appointment of Fouad Namouni, M.D., as President, Research & Development
Aug 04, 2020
Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Jul 30, 2020
Blueprint Medicines Reports Second Quarter 2020 Financial Results
Jul 23, 2020
Blueprint Medicines to Report Second Quarter 2020 Financial Results on Thursday, July 30, 2020
Jul 14, 2020
Blueprint Medicines Announces Global Collaboration with Roche to Develop and Commercialize Pralsetinib for Patients with RET-Altered Cancers
Jul 02, 2020
Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Jun 29, 2020
Blueprint Medicines Announces Publication in The Lancet Oncology Showing Durable Clinical Benefits of AYVAKIT(TM) (avapritinib) in NAVIGATOR Trial Patients with PDGFRA D842V Mutant GIST
Jun 06, 2020
Blueprint Medicines Presents Updated Part 1 Data from PIONEER Trial of Avapritinib Showing Robust Reductions in Cutaneous Disease Symptoms in Patients with Indolent Systemic Mastocytosis
Jun 03, 2020
Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
May 29, 2020
Blueprint Medicines Announces Data Presentations at ASCO20 Highlighting Deep, Durable Clinical Activity and Well-Tolerated Safety Profile of Pralsetinib Across Broad Range of RET Fusion-Positive Tumors
May 27, 2020
Blueprint Medicines to Present at Upcoming Investors Conferences
May 26, 2020
Blueprint Medicines to Host Conference Call to Review Updated Clinical Data for Pralsetinib in RET-Altered Cancers on Friday, May 29, 2020
May 15, 2020
Blueprint Medicines Receives Complete Response Letter from FDA for Avapritinib New Drug Application for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
May 14, 2020
Blueprint Medicines Announces Data Presentations Highlighting Significant Progress in Advancing RET-Altered Cancer and Systemic Mastocytosis Programs
Apr 28, 2020
Blueprint Medicines Announces Top-line Results from Phase 3 VOYAGER Trial of Avapritinib versus Regorafenib in Patients with Advanced Gastrointestinal Stromal Tumor
Mar 16, 2020
Blueprint Medicines Announces Part 1 Results from PIONEER Trial Showing Broad Activity of Avapritinib Across Measures of Mast Cell Burden, Clinical Outcomes and Quality of Life in Indolent Systemic Mastocytosis
‹‹
Page 2
››
Latest News
May 26, 2024
Pye-Barker Fire & Safety Acquires Alarms Industry Stalwart Security Solutions Inc. in Connecticut
May 26, 2024
Italy opposes use of weapons supplied to Ukraine in Russia
May 26, 2024
NASDAQ: LI: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Securities Class Action Lawsuit...
May 26, 2024
Turbulence over Turkey injures 12 on Qatar Airways flight
May 26, 2024
OffshoreCorpTalk Celebrates 15 Years of Community and Innovation
May 26, 2024
Hyundai Mobis Hosts Investment Conference in Silicon Valley!
May 26, 2024
Noumea airport to stay closed to commercial flights until June 2: operator
May 26, 2024
Zelensky invites Biden and Xi to attend Ukraine peace summit
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events